{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:21:47Z","timestamp":1787869307114,"version":"build-2784847793"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005771","name":"Dokuz Eyl\u00fcl \u00dcniversitesi","doi-asserted-by":"publisher","award":["2012KBSAG092"],"award-info":[{"award-number":["2012KBSAG092"]}],"id":[{"id":"10.13039\/501100005771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005771","name":"Dokuz Eyl\u00fcl \u00dcniversitesi","doi-asserted-by":"publisher","award":["2009KBSAG029"],"award-info":[{"award-number":["2009KBSAG029"]}],"id":[{"id":"10.13039\/501100005771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229104","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T13:38:00Z","timestamp":1582810680000},"page":"e0229104","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-5332","authenticated-orcid":true,"given":"Seda","family":"Baykal-K\u00f6se","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"Acikgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4069-6105","authenticated-orcid":true,"given":"Ahmet Sinan","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6yk\u00fc","family":"G\u00f6n\u00fcl Geyik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman U\u011fur","family":"Sezerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcner Hayri","family":"\u00d6zsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2762-0942","authenticated-orcid":true,"given":"Zeynep","family":"Y\u00fcce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"pone.0229104.ref001","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"A Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"key":"pone.0229104.ref002","first-page":"3343","volume":"96","author":"MWN Deininger","year":"2000","journal-title":"The molecular biology of chronic myeloid leukemia Review article The molecular biology of chronic myeloid leukemia"},{"key":"pone.0229104.ref003","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia","volume":"376","author":"A Hochhaus","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0229104.ref004","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.3747\/co.v18i2.391","article-title":"Monitoring response and resistance to treatment in chronic myeloid leukemia","volume":"18","author":"S Assouline","year":"2011","journal-title":"Curr Oncol"},{"key":"pone.0229104.ref005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clml.2013.03.018","article-title":"Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment options","volume":"13","author":"EJ Jabbour","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"pone.0229104.ref006","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.leu.2402889","article-title":"Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back","volume":"17","author":"N von Bubnoff","year":"2003","journal-title":"Leukemia"},{"key":"pone.0229104.ref007","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.2174\/1381612811319300006","article-title":"The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells","volume":"19","author":"M Cipolleschi","year":"2013","journal-title":"Curr Pharm Des"},{"key":"pone.0229104.ref008","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.4161\/15384101.2014.964107","article-title":"The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy","volume":"13","author":"E Rovida","year":"2014","journal-title":"Cell Cycle"},{"key":"pone.0229104.ref009","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/0008-5472.CAN-14-1174","article-title":"Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy","volume":"74","author":"K Kemper","year":"2014","journal-title":"Cancer Res"},{"key":"pone.0229104.ref010","first-page":"3269","author":"S Bhatia","year":"2017","journal-title":"Targeting epithelial\u2013mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring"},{"key":"pone.0229104.ref011","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12032-017-0980-8","article-title":"Epithelial-to-mesenchymal transition in tumor progression","volume":"34","author":"E Prieto-Garc\u00eda","year":"2017","journal-title":"Med Oncol"},{"key":"pone.0229104.ref012","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"R Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"pone.0229104.ref013","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/35000025","article-title":"The transcription factor Snail controls epithelial\u2013mesenchymal transitions by repressing E-cadherin expression","volume":"2","author":"A Cano","year":"2000","journal-title":"Nat Cell Biol"},{"key":"pone.0229104.ref014","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial\u2013mesenchymal transition during tumor progression","volume":"17","author":"MA Huber","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"pone.0229104.ref015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/pr.55.3.4","article-title":"Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib","volume":"55","author":"MWN Deininger","year":"2003","journal-title":"Pharmacol Rev"},{"key":"pone.0229104.ref016","unstructured":"HIGHLIGHTS OF PRESCRIBING INFORMATION. [cited 4 Mar 2018]. http:\/\/www.iclusig.com\/pi"},{"key":"pone.0229104.ref017","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/pr.55.3.4","article-title":"Specific targeted therapy of chronic myelogenous leukemia with imatinib","volume":"55","author":"MWN Deininger","year":"2003","journal-title":"Pharmacol Rev"},{"key":"pone.0229104.ref018","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1158\/1078-0432.CCR-07-5015","article-title":"Nilotinib","volume":"14","author":"MW Deininger","year":"2008","journal-title":"Clin Cancer Res"},{"key":"pone.0229104.ref019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00280-011-1688-7","article-title":"A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects","volume":"69","author":"R Abbas","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"pone.0229104.ref020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-8722-5-23","article-title":"Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation","volume":"5","author":"N Takahashi","year":"2012","journal-title":"J Hematol Oncol"},{"key":"pone.0229104.ref021","doi-asserted-by":"crossref","first-page":"e0141090","DOI":"10.1371\/journal.pone.0141090","article-title":"Enhanced G2\/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells","volume":"10","author":"E Acikgoz","year":"2015","journal-title":"PLoS One"},{"key":"pone.0229104.ref022","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/1574892811666160128151437","article-title":"Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process","volume":"11","author":"K Zhang","year":"2016","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"pone.0229104.ref023","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.urolonc.2014.01.005","article-title":"CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition","volume":"32","author":"W Liang","year":"2014","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"pone.0229104.ref024","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/onc.2015.100","article-title":"Syntenin regulates TGF-\u03b21-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-\u03b2 type I receptor internalization","volume":"35","author":"C Hwangbo","year":"2016","journal-title":"Oncogene"},{"key":"pone.0229104.ref025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1535-6108(03)00304-0","article-title":"Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion","volume":"4","author":"Z Lu","year":"2003","journal-title":"Cancer Cell"},{"key":"pone.0229104.ref026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2017.11.010","article-title":"E-cadherin: Its dysregulation in carcinogenesis and clinical implications","volume":"121","author":"SHM Wong","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"pone.0229104.ref027","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte\u2013Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML","volume":"351","author":"CHM Jamieson","year":"2004","journal-title":"N Engl J Med"},{"key":"pone.0229104.ref028","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nrc2019","article-title":"Leukaemia Stem Cells: Homing in on CD44","volume":"6","author":"S Seton-Rogers","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"pone.0229104.ref029","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"L Jin","year":"2006","journal-title":"Nat Med"},{"key":"pone.0229104.ref030","first-page":"493","volume":"90","author":"MK Hertweck","year":"2011","journal-title":"CD44 in hematological neoplasias To cite this version: HAL Id: hal-00610424 CD44 in hematological neoplasias"},{"key":"pone.0229104.ref031","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells","volume":"12","author":"DS Krause","year":"2006","journal-title":"Nat Med"},{"key":"pone.0229104.ref032","first-page":"1595","volume":"129","author":"TL Holyoake","year":"2017","journal-title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence"},{"key":"pone.0229104.ref033","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"AS Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"pone.0229104.ref034","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cas.13155","article-title":"Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications","volume":"108","author":"T Ishiguro","year":"2017","journal-title":"Cancer Sci"},{"key":"pone.0229104.ref035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1254\/jphs.13025FP","article-title":"Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by doxorubicin possess tumor-initiating-cell properties","volume":"122","author":"H Xin","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"pone.0229104.ref036","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.matbio.2004.06.004","article-title":"Fibroblast growth factor-2 in serum-free medium is a potent mitogen and reduces dedifferentiation of human ear chondrocytes in monolayer culture","volume":"23","author":"EW Mandl","year":"2004","journal-title":"Matrix Biol"},{"key":"pone.0229104.ref037","first-page":"251","article-title":"The Effects of Growth Factors on Multicellular Spheroids Formed by Chick Embryonic Retinal Cells","volume":"51","author":"T Matsuo","year":"1997","journal-title":"Acta Med Okayama"},{"key":"pone.0229104.ref038","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1177\/0963689717724794","article-title":"Fully Dedifferentiated Chondrocytes Expanded in Specific Mesenchymal Stem Cell Growth Medium with FGF2 Obtains Mesenchymal Stem Cell Phenotype In Vitro but Retains Chondrocyte Phenotype In Vivo","volume":"26","author":"J Lee","year":"2017","journal-title":"Cell Transplant"},{"key":"pone.0229104.ref039","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jmcb\/mjs010","article-title":"Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness","volume":"4","author":"A Puissant","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"pone.0229104.ref040","doi-asserted-by":"crossref","first-page":"n\/a","DOI":"10.1002\/jcb.22467","article-title":"Wnt signaling in hematopoiesis: Crucial factors for self-renewal, proliferation, and cell fate decisions","volume":"109","author":"FJT Staal","year":"2010","journal-title":"J Cell Biochem"},{"key":"pone.0229104.ref041","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2018.07.001","article-title":"Hybrid epithelial\/mesenchymal phenotype(s): The \u2018fittest\u2019 for metastasis?","volume":"1870","author":"MK Jolly","year":"2018","journal-title":"Biochim Biophys Acta\u2014Rev Cancer"},{"key":"pone.0229104.ref042","first-page":"1","article-title":"CD44, hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells","volume":"6","author":"M Z\u00f6ller","year":"2015","journal-title":"Front Immunol"},{"key":"pone.0229104.ref043","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0145-2126(84)90143-7","article-title":"Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells","volume":"8","author":"PAT Tetteroo","year":"1984","journal-title":"Leuk Res"},{"key":"pone.0229104.ref044","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cyto.990090415","article-title":"Flow cytometric analysis of the phenotypic changes in tumour cell lines following TPA induction","volume":"9","author":"MJ Zanyk","year":"1988","journal-title":"Cytometry"},{"key":"pone.0229104.ref045","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/278364a0","article-title":"Induction of erythroid differentiation in the human leukaemia cell line K562","volume":"278","author":"LC ANDERSSON","year":"1979","journal-title":"Nature"},{"key":"pone.0229104.ref046","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0045-6039(84)90033-2","article-title":"Human leukemia K-562 cells: induction of erythroid differentiation by 5-azacytidine","volume":"14","author":"R Gambari","year":"1984","journal-title":"Cell Differ"},{"key":"pone.0229104.ref047","first-page":"6327","article-title":"Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease","volume":"46","author":"GL Bianchi Scarr\u00e0","year":"1986","journal-title":"Cancer Res"},{"key":"pone.0229104.ref048","first-page":"4544","article-title":"Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562","volume":"47","author":"GP Tonini","year":"1987","journal-title":"Cancer Res"},{"key":"pone.0229104.ref049","article-title":"Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2","volume":"5","author":"J-G Ren","year":"2010","journal-title":"PLoS One"},{"key":"pone.0229104.ref050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1089\/scd.2016.0262","article-title":"Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia","volume":"26","author":"A Chorzalska","year":"2017","journal-title":"Stem Cells Dev"},{"key":"pone.0229104.ref051","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1242\/dev.020867","article-title":"Epigenetic reprogramming and induced pluripotency","volume":"136","author":"K Hochedlinger","year":"2009","journal-title":"Development"},{"key":"pone.0229104.ref052","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cell.2007.02.010","article-title":"Genetic and Epigenetic Regulators of Pluripotency","volume":"128","author":"MA Surani","year":"2007","journal-title":"Cell"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T13:38:19Z","timestamp":1582810699000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229104"}},"subtitle":[],"editor":[{"given":"Persio","family":"Dello Sbarba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229104","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]}}}